On March 20 Shares of Denali Therapeutics Inc. (DNLI) were valued at $21.86 and moved -1.58% as of a recent closing trade. A total volume of 0.54 million shares were traded versus to average volume of 0.4 million shares.
Denali Therapeutics Inc. (DNLI) held 96.19 million outstanding shares currently. The company have shares float of 86.21 million. Now have a look at past performance (weekly performance to year to date performance) how Denali Therapeutics Inc. (DNLI) has been moved; whether it performed well or not. DNLI reported a change of -10.30% over the last week and performed 1.82% over the last month while its year to date (YTD) performance revealed an activity trend of 5.81%. The stock’s quarterly performance specifies a shift of 10.96%, and its last twelve month performance is stands at -0.46% while moved 16.71% for the past six months.
Twenty-day SMA is useful at identifying swing trading trends lasting twenty days. Shorter moving average timeframes are more sensitive to price fluctuations and can pick up on trend changes more quickly than longer-term moving averages. However, these more frequent signals may also result in more “whipsaws”, resulting in erroneous trade signals. DNLI recently closed with fall of -1.53% to its twenty-Day SMA. This short time frame picture represents a downward movement of current price over average price of last twenty days.
52 week High and Low
Denali Therapeutics Inc. (DNLI) shares have been seen trading -12.73% off its 52 week- peak value and changed 77.44% from its 52 week-bottom price value. The “percentage off the 52-week high or low” refers to when a stock current price is relative to where it has traded over the last 52 weeks. This gives investors an idea of how much the security has moved in the last year and whether it is trading near the top, middle or bottom of the range.
Analysts have suggested a mean rating of 2.40 on the shares. This is based on a 1-5 numeric scale where Rating Scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell.
Relative Strength Index (RSI)
Denali Therapeutics Inc. (DNLI)’s Relative Strength Index (RSI) is 48.27. RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions. Average True Range (14) for Denali Therapeutics Inc. (DNLI) is stands at 1.26. ATR is a volatility indicator. Volatility measures the strength of the price action, and is often overlooked for clues on market direction.
Over the past week, the company showed volatility of 5.34%. Moving out to look at the previous month volatility move, the stock is at 5.57%.